-
Chemo Shortage Didn’t Materialize ‘The Way We Initially Feared’
This March, LUNGevity Foundation partnered with CURE for their “Speaking Out” video series, inviting Amy Moore, PhD, vice president of global engagement and patient partnerships at LUNGevity...
IN THE SPOTLIGHT
-
Caregivers: Planning the Self-Care Journey
This webinar explains the phases of the caregiving cycle and offers tips and strategies for meeting the challenges of each phase. The discussion features Michelle Bolden, founder... -
Cancer Grand Challenges Summit 2024: No Time to Waste in Addressing Some of Toughest Challenges in Cancer
Read time: 4 minutes I just returned from the Cancer Grand Challenges Summit, held March 5–8, 2024 in London, England. Cancer Grand Challenges was launched in 2020 as a... -
Leveraging Genetics to Understand Why Younger Adults Are Developing Lung Cancer
Read Time: 5 minutes It’s a mystery that has been baffling researchers: Why do some people develop lung cancer in their 20s or 30s? While we used to think lung cancer was only... -
FDA Approves New Treatment Option: Osimertinib Plus Chemotherapy for EGFR+ NSCLC
The US Food and Drug Administration (FDA) approved a new treatment option for people diagnosed with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors... -
Using T cells to Tackle Drug Resistance in EGFR+ Lung Cancer
Approximately 10%-15% of patients with non-small cell lung cancer have tumors with mutations in the EGFR (epidermal growth factor receptor) gene. EGFR mutations are known to drive... -
Lung Cancer Masterclass: Get Smart About Lung Cancer
In the past five years, the lung cancer community has seen an astonishing number of new treatments. As our understanding of lung cancer has deepened, the older treatment approaches... -
HOPE Summit 2024 in Atlanta, GA
Registration is still open for HOPE Summit 2024, which we are excited to host in Atlanta, Georgia, this year. This weekend-long conference combines learning how to live with lung... -
EGFR Virtual Meetup
EGFR patients/survivors - Join us the 1st Wednesday of every month to connect with others who share common experiences and build your community.
Chemo Shortage Didn’t Materialize ‘The Way We Initially Feared’
Chemo Shortage Didn’t Materialize ‘The Way We Initially Feared’
This March, LUNGevity Foundation partnered with CURE for their “Speaking Out” video series, inviting Amy Moore, PhD, vice president of global engagement and patient partnerships at LUNGevity Foundation, to discuss recent chemotherapy shortages. During the interview, Dr. Moore addressed the critical issues posed by the chemotherapy shortage, offering valuable insights into its origins, impact on people with lung cancer, available alternatives, and ongoing efforts to address disparities. Her…
FDA Approves Amivantamab-vmjw for EGFR Exon 20 Insertion–Mutated NSCLC
Addition of Nivolumab to Chemotherapy in EGFR-Mutant Metastatic NSCLC After Disease Progression on Prior Therapy
Addition of Nivolumab to Chemotherapy in EGFR-Mutant Metastatic NSCLC After Disease Progression on Prior Therapy
Risks of Cardiovascular Disease in Patients Receiving Therapies for Lung Cancer
Osimertinib vs Sequential Gefitinib/Osimertinib in Advanced EGFR-Mutant NSCLC
Osimertinib With Chemotherapy for EGFR-Mutated NSCLC
Amivantamab-vmjw in NSCLC With EGFR Exon 20 Insertion Mutations
Dr Rodriguez on Treating Patients With Lung Cancer Harboring Multiple Actionable Mutations
Dr Rodriguez on Treating Patients With Lung Cancer Harboring Multiple Actionable Mutations
Treating Women With Lung Cancer: Screening, Treatment, and Sexual and Reproductive Health
Treating Women With Lung Cancer: Screening, Treatment, and Sexual and Reproductive Health
FDA Grants BTD to Sunvozertinib in EGFR Exon20+ NSCLC
The Rise of ADC Anticancer Drugs: Enhertu Sparks Global Craze and Competition in the Pharmaceutical Industry
The Rise of ADC Anticancer Drugs: Enhertu Sparks Global Craze and Competition in the Pharmaceutical Industry
Caregivers: Planning the Self-Care Journey
Caregivers: Planning the Self-Care Journey
This webinar explains the phases of the caregiving cycle and offers tips and strategies for meeting the challenges of each phase. The discussion features Michelle Bolden, founder and chief education officer for Call For Caring Inc., a nonprofit organization educating and uplifting family caregivers in Atlanta. Michelle also hosts two podcasts -- "Call For Caring on Purpose" and "The Empowerment Hour." The webinar was recorded on March 7, 2024, as a Facebook Live event. It is hosted…
Cancer Grand Challenges Summit 2024: No Time to Waste in Addressing Some of Toughest Challenges in Cancer
Cancer Grand Challenges Summit 2024: No Time to Waste in Addressing Some of Toughest Challenges in Cancer
Read time: 4 minutesI just returned from the Cancer Grand Challenges Summit, held March 5–8, 2024 in London, England. Cancer Grand Challenges was launched in 2020 as a collaboration between Cancer Research UK and the National Cancer Institute in the US, whereby they provide $25 million to international, multi-institutional teams working to address some of the most perplexing issues in the cancer field. I am LUNGevity’s representative on Team CANCAN, which is working to understand and treat…
General Virtual Meetup
General Virtual Meetup
For patients/survivors - Join us every Tuesday for this general meetup for those impacted by lung cancer.Register in advance for this meeting:After registering, you will receive a confirmation email containing information about joining the meeting.
Leveraging Genetics to Understand Why Younger Adults Are Developing Lung Cancer
Leveraging Genetics to Understand Why Younger Adults Are Developing Lung Cancer
Read Time: 5 minutesIt’s a mystery that has been baffling researchers: Why do some people develop lung cancer in their 20s or 30s? While we used to think lung cancer was only caused by exposure to tobacco and environmental factors like radon, researchers are starting to learn that the development of lung cancer, particularly in younger adults, could have a hereditary component. LUNGevity partnered with the Lung Cancer Initiative, a leading nonprofit in North Carolina, to support…
FDA Approves New Treatment Option: Osimertinib Plus Chemotherapy for EGFR+ NSCLC
FDA Approves New Treatment Option: Osimertinib Plus Chemotherapy for EGFR+ NSCLC
The US Food and Drug Administration (FDA) approved a new treatment option for people diagnosed with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors have EGFR exon 19 deletions or exon 21 L858R mutations.Prior to this approval, treatment with osimertinib alone was the gold-standard targeted therapy for this population. The recent approval offers another option to patients – the combination of osimertinib with chemotherapy. This FDA approval is based on the…
Using T cells to Tackle Drug Resistance in EGFR+ Lung Cancer
Using T cells to Tackle Drug Resistance in EGFR+ Lung Cancer
Approximately 10%-15% of patients with non-small cell lung cancer have tumors with mutations in the EGFR (epidermal growth factor receptor) gene. EGFR mutations are known to drive cancer growth. Many patients living with EGFR-positive lung cancer benefit from targeted therapies called tyrosine kinase inhibitors (TKIs). TKIs, such as osimertinib, can help patients by specifically blocking the effect of these mutations and reducing tumor growth. However, TKI-treated tumors eventually develop drug…
Fertility Preservation and Cancer
Fertility Preservation and Cancer
Medications and treatments for lung cancer can affect fertility in both women and men. This video covers how to work with a reproductive endocrinologist, the first steps after getting your diagnosis, what to consider before starting treatment, and options after completing treatment.
Lung Cancer Masterclass: Get Smart About Lung Cancer
Lung Cancer Masterclass: Get Smart About Lung Cancer
In the past five years, the lung cancer community has seen an astonishing number of new treatments. As our understanding of lung cancer has deepened, the older treatment approaches have also become more effective and efficient. These options are fantastic steps toward improving the overall survival and quality of life for people living with lung cancer, but it can be difficult for patients and caregivers to keep track of the new drug treatments and scientific advancements. …
Finding Balance in Life and Treatment with Marnie Clark
Finding Balance in Life and Treatment with Marnie Clark
The symptoms that led Marnie Clark to her doctor were unusual. Her leg was feeling “weird,” but it was more of an annoyance than something she was concerned about. Then came an issue she couldn’t ignore—her leg was paralyzed, and she couldn’t move it. “The doctor thought it had to be something physically wrong with my leg, but over the previous two years I started to take my health seriously and was working with a personal trainer. I was feeling strong, so it didn’t make sense that I had a…
HOPE Summit 2024 in Atlanta, GA
HOPE Summit 2024 in Atlanta, GA
Atlanta, GA
Registration is still open for HOPE Summit 2024, which we are excited to host in Atlanta, Georgia, this year. This weekend-long conference combines learning how to live with lung cancer and creating friendships that last beyond the event.HOPE Summit is a unique event for all people impacted by lung cancer—those living with lung cancer, survivors, caregivers, and now whole families. The weekend features medical experts, inspirational speakers, wellness activities, peer-to-peer connections, and…
Questions to Ask About Clinical Trials
Questions to Ask About Clinical Trials
Asking your doctor and medical team questions about clinical trials is a helpful way to decide if they are a good fit for you. You may already have some in mind, but a few basic questions to ask and get answered before making a decision are:Do you know of any clinical trials for my type and stage of lung cancer?What are the benefits and risks of this clinical trial?What are the eligibility guidelines?How long does the study last?Will you still be in charge of my care?What are the costs, and…
Clinical Trial Phases
Clinical Trial Phases
The four phases of lung cancer clinical trials each serve a different and important purpose. From testing the safety of a new treatment to its effectiveness and long-term outcomes, this short video explains how researchers use clinical trials for new lung cancer treatments.Phases of a Clinical Trial:1. Safety of the new treatment 2. Does the cancer respond to the treatment 3. Is this new treatment better than the current options 4. Studies the long-term benefits and side effects
Helpful Apps for People Living with Cancer
Helpful Apps for People Living with Cancer
As mobile apps become more ingrained in our lives, it’s natural to look for ones that can help manage a cancer diagnosis. As for which app to choose, it really comes down to what you’re looking for, what you’re comfortable with, and what fits your needs. This list of helpful apps for people living with cancer includes ones that range from very basic, essentially a mobile pen and piece of paper, to all-in-one solutions that make medication tracking, document management, and…
Drs. Susumu Kobayashi and Alexandre Reuben Announced as Recipients of EGFR Resisters/LUNGevity Research Award
Drs. Susumu Kobayashi and Alexandre Reuben Announced as Recipients of EGFR Resisters/LUNGevity Research Award
LUNGevity Foundation is thrilled to announce the recipients of the EGFR Resisters/LUNGevity Research Award for EGFR-Positive Lung Cancer.EGFR Resisters, a vibrant patient-led community advocating for improved treatment options for patients with EGFR-positive lung cancer, has partnered with LUNGevity for the second time to support high-impact research focused on EGFR-positive lung cancer.“We are pleased to partner with LUNGevity again on patient-directed research to address the unmet needs of…
LUNGevity Announces $1.2M in Lung Cancer Workforce Development Research Awards
LUNGevity Announces $1.2M in Lung Cancer Workforce Development Research Awards
LUNGevity Foundation is proud to announce the recipients of four awards to bolster the lung cancer research workforce— the Career Development Award, the VA Research Scholar Award, the Health Equity and Inclusiveness Research Fellow Award, and the ASTRO-LUNGevity Residents/Fellows in Radiation Oncology Seed Grant.“Progress in lung cancer research is only possible with a vibrant and diverse thoracic oncology workforce,” notes Upal Basu Roy, PhD, MPH, executive director, LUNGevity Research. “We…
Finding (Mental) Peace this Holiday Season
Finding (Mental) Peace this Holiday Season
The holidays are stressful enough without having to deal with lung cancer. LUNGevity is here to help.This discussion of the mental health challenges we face in the lung cancer community includes strategies for coping with a lung cancer diagnosis, stigma, and holiday anxiety. With the daylight getting shorter, we also discuss tips to address seasonal affective disorder. The free support programs and services available through LUNGevity for patients and caregivers are highlighted.This webinar…
Treatment & Research Takeaways: ESMO 2023 Meeting
Treatment & Research Takeaways: ESMO 2023 Meeting
The European Society for Medical Oncology (ESMO) recently held its annual conference from October 20 – 24, 2023 in Madrid, Spain. ESMO represents one of the largest gatherings of the international oncology community, and this year’s meeting had over 30,000 registered attendees from around the world. Though October 19th brought record rainfall to Madrid, breaking a 100-year record, the rain in Spain didn’t dampen the palpable excitement of this year’s meeting. This was an especially…
What Is a Clinical Trial
What Is a Clinical Trial
Lung cancer clinical trials are carefully designed research studies to evaluate and learn more about new drugs and treatments. They give people the ability to participate in lung cancer research and access to new treatments that otherwise may not be available to them, all under the close supervision of medical experts.
Watch Recorded Expert Sessions From ILCSC
Watch Recorded Expert Sessions From ILCSC
The International Lung Cancer Survivorship Conference (ILCSC) is a free virtual educational conference for people with lung cancer, caregivers, and advocates. The 2023 conference was held September 22-23. The recorded sessions from this conference are available to registered participants through December 21, 2023, at www.lungevity.org/ilcsc. If you did not register for the conference but would like to view the recordings, you may still register for free access. The recordings are…